Compare Devon Energy Corp (DVN) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs Hinge Health Inc. Class A Common Stock — how do they compare? Devon Energy Corp trades at $50.23 (market cap $55.23B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Devon Energy Corp is far larger — about 6.5× Hinge Health Inc. Class A Common Stock's market cap, and Devon Energy Corp pays a 2.55% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| DVN | HNGE | |
|---|---|---|
Market Cap | $55.23B | $8.48B |
Volume | 10,032,111 | 879,799 |
Sector | Energy | Health |
52-Week High | $52.07 | $105.14 |
52-Week Low | $31.74 | $31.17 |
Typical Hold Time | 136 Days | 0 Days |
Enterprise Value | $65.97B | $8.10B |
Dividend Yield | 2.55% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $50.21, up 2.55% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $62.44 implying significant upside. Recent financials show revenue of $17.19B in 2025 with a net income margin of 16.67%, while valuation ratios like a P/E of 10.92 appear attractive. Activist investor Toms Capital is urging strategic review, including a potential sale, as highlighted in recent news (CNBC, 2026-09-23).
The outlook is positive given strong analyst support (72% buy ratings) and projected 2026 revenue growth to $19.7B. Key risks include oil price volatility and execution of potential asset sales. The stock presents a value opportunity with upside to price targets, though dependent on commodity markets and corporate strategy developments.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
